Literature DB >> 7628865

Modulation of inflammatory arthritis by inhibition of poly(ADP ribose) polymerase.

R Miesel1, M Kurpisz, H Kröger.   

Abstract

Poly(ADPR) polymerase (PARP; EC 2.4.2.30) is a nuclear enzyme, which, when activated by oxygen- and nitrogen-radical-induced DNA strand breaks, transfers ADP ribose units to nuclear proteins and initiates apoptosis by depletion of cellular NAD and ATP pools. The present study investigates whether the oxidative stress-dependent activation of PARP plays a role in the etiopathogenesis of arthritis. The antiarthritic reactivity of the biogenic PARP inhibitor nicotinamide was tested in DBA/1 x B10A(4R) mice suffering from potassium peroxochromate-induced arthritis. Daily doses of 4 mmol/kg of NA suppressed the arthritis by 35% and inhibited the phagocytic generation of reactive oxygen species, which increases sixfold during the development of arthritis. The onset, progression, and remission of arthritis correlated positively to the phorbolester-activated respiratory burst of neutrophils and monocytes, and a dose-dependent inhibition of NADPH oxidase activity was determined with human phagocytes. Our data support the hypothesis that oxidative stress-induced alterations in cellular signal transduction pathways play a pivotal role in the development of arthritis, which can be suppressed by the simultaneous inhibition of poly(ADPR) polymerase and NADPH oxidase.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7628865     DOI: 10.1007/bf01534394

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  20 in total

1.  Effects of altered [ADP-ribose]n metabolism on expression of fetal functions by adult hepatocytes.

Authors:  F R Althaus; S D Lawrence; Y Z He; G L Sattler; Y Tsukada; H C Pitot
Journal:  Nature       Date:  1982-11-25       Impact factor: 49.962

2.  Naturally-occurring antibodies to poly(ADP-ribose) in patients with systemic lupus erythematosus.

Authors:  Y Kanai; Y Kawaminami; M Miwa; T Matsushima; T Sugimura
Journal:  Nature       Date:  1977-01-13       Impact factor: 49.962

3.  [Poly-(ADP ribose) synthesis and regulation disorders in disease].

Authors:  H Altmann
Journal:  Wien Klin Wochenschr       Date:  1983-12-23       Impact factor: 1.704

4.  Nicotinamide inhibits nitric oxide synthase mRNA induction in activated macrophages.

Authors:  C Pellat-Deceunynck; J Wietzerbin; J C Drapier
Journal:  Biochem J       Date:  1994-01-01       Impact factor: 3.857

5.  Reactive nitrogen intermediates, antinuclear antibodies and copper-thionein in serum of patients with rheumatic diseases.

Authors:  R Miesel; M Zuber
Journal:  Rheumatol Int       Date:  1993       Impact factor: 2.631

6.  Nitric oxide activation of poly(ADP-ribose) synthetase in neurotoxicity.

Authors:  J Zhang; V L Dawson; T M Dawson; S H Snyder
Journal:  Science       Date:  1994-02-04       Impact factor: 47.728

7.  3-aminobenzamide protects the mouse thymocytes in vitro from dexamethasone-mediated apoptotic cell death and cytolysis without changing DNA strand breakage.

Authors:  J Hoshino; G Beckmann; H Kröger
Journal:  J Steroid Biochem Mol Biol       Date:  1993-02       Impact factor: 4.292

8.  Inhibitors of poly(ADP-ribose) polymerase increase antibody class switching.

Authors:  P Shockett; J Stavnezer
Journal:  J Immunol       Date:  1993-12-15       Impact factor: 5.422

9.  Antiinflammatory effects of NADPH oxidase inhibitors.

Authors:  R Miesel; D Sanocka; M Kurpisz; H Kröger
Journal:  Inflammation       Date:  1995-06       Impact factor: 4.092

10.  Type II collagen-induced arthritis in mice. I. Major histocompatibility complex (I region) linkage and antibody correlates.

Authors:  P H Wooley; H S Luthra; J M Stuart; C S David
Journal:  J Exp Med       Date:  1981-09-01       Impact factor: 14.307

View more
  18 in total

1.  Enhancing the inhibitory effect of nicotinamide upon collagen II induced arthritis in mice using N-acetylcysteine.

Authors:  H Kröger; A Hauschild; M Ohde; K Bache; W P Voigt; W Ehrlich
Journal:  Inflammation       Date:  1999-04       Impact factor: 4.092

Review 2.  Parthanatos: mitochondrial-linked mechanisms and therapeutic opportunities.

Authors:  Amos A Fatokun; Valina L Dawson; Ted M Dawson
Journal:  Br J Pharmacol       Date:  2014-04       Impact factor: 8.739

Review 3.  Neutrophil apoptosis in autoimmunity.

Authors:  Stanford L Peng
Journal:  J Mol Med (Berl)       Date:  2005-12-16       Impact factor: 4.599

4.  Enhancement of the effect of methotrexate on collagen II induced arthritis in mice by nicotinamide.

Authors:  H Kröger; A Hauschild; M Ohde; W Thefeld; D Krüger; K Bache; W Ehrlich
Journal:  Inflammation       Date:  1998-06       Impact factor: 4.092

5.  PARP-1 hyperactivation and reciprocal elevations in intracellular Ca2+ during ROS-induced nonapoptotic cell death.

Authors:  Fengjiao Zhang; Ruiye Xie; Frances M Munoz; Serrine S Lau; Terrence J Monks
Journal:  Toxicol Sci       Date:  2014-04-20       Impact factor: 4.849

6.  Priming of NADPH oxidase by tumor necrosis factor alpha in patients with inflammatory and autoimmune rheumatic diseases.

Authors:  R Miesel; R Hartung; H Kroeger
Journal:  Inflammation       Date:  1996-08       Impact factor: 4.092

7.  Synergistic effects of thalidomide and poly (ADP-ribose) polymerase inhibition on type II collagen-induced arthritis in mice.

Authors:  H Kröger; R Miesel; A Dietrich; M Ohde; E Rajnavölgyi; H Ockenfels
Journal:  Inflammation       Date:  1996-04       Impact factor: 4.092

8.  The Val762Ala polymorphism in the poly(ADP-ribose) polymerase-1 gene is not associated with susceptibility in Turkish rheumatoid arthritis patients.

Authors:  Ilhan Onaran; Gülçin Tezcan; Levent Ozgönenel; Esra Cetin; Alper Tunga Ozdemir; Gönül Kanigür-Sultuybek
Journal:  Rheumatol Int       Date:  2008-11-22       Impact factor: 2.631

9.  Regulation of myofibroblast differentiation by poly(ADP-ribose) polymerase 1.

Authors:  Biao Hu; Zhe Wu; Polla Hergert; Craig A Henke; Peter B Bitterman; Sem H Phan
Journal:  Am J Pathol       Date:  2013-01       Impact factor: 4.307

Review 10.  Diverse therapeutic efficacies and more diverse mechanisms of nicotinamide.

Authors:  Seon Beom Song; Jin Sung Park; Gu June Chung; In Hye Lee; Eun Seong Hwang
Journal:  Metabolomics       Date:  2019-10-05       Impact factor: 4.290

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.